Preoperative PSA velocity and doubling time do not predict adverse pathologic features or biochemical recurrence after radical prostatectomy

Urology

Volumn 57, Issue 3, 2001, Pages 476-480

  Freedland, Stephen J ^a   Dorey, Frederick ^a   Aronson, William J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ACCURACY; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOLOGY; PREDICTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RACE DIFFERENCE; RECURRENT CANCER; SEMINAL VESICLE; TIME; VELOCITY;

AGED; ANALYSIS OF VARIANCE; BIOPSY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; REGRESSION ANALYSIS; TIME FACTORS;

EID: 0035096872     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(00)01016-5     Document Type: Article

References (21)

1. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer
2. Early prostate-specific antigen relapse after radical retropubic prostatectomy; prediction on the basis of preoperative and postoperative tumor characteristics
3. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update
4. Pretreatment prostate-specific antigen doubling times; clinical utility of this predictor of prostate cancer behavior
5. Pretreatment prostate specific antigen doubling times; use in patients before radical prostatectomy
6. Role of prostate-specific antigen velocity in prediction of final pathologic stage in men with localized prostate cancer
7. Effect of cystoscopy, prostate biopsy, and transurethral resection of prostate on serum prostate-specific antigen concentration
8. Multivariate analysis of race and adverse pathological findings following radical prostatectomy
9. Race is not an independent predictor of biochemical recurrence following radical prostatectomy in an equal access medical center
10. Classification of prostatic carcinoma
11. Evaluation of radical prostatectomy specimens. A comparative analysis of sampling methods
12. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men
13. Prostate specific antigen and Gleason grade; an immunohistochemical study of prostate cancer
14. Evaluation of changes in prostate specific antigen in clinically localized prostate cancer managed without initial therapy
15. Prostate specific antigen velocity as a measure of the natural history of prostate cancer; defining a 'rapid riser' subset
16. Clinical characteristics in black and white men with prostate cancer in an equal access medical center
17. Age-specific reference ranges for serum prostate-specific antigen in black men
18. A prospective study of the serum prostate specific antigen concentrations and Gleason histologic scores of black and white men with prostate carcinoma
19. Predictors of first repeat biopsy cancer detection with suspected local stage prostate cancer
20. Observations of prostate specific antigen doubling time in Japanese patients with nonmetastatic prostate carcinoma